BHST: BioHarvest Sciences Company Short-Term Debt

Symbol and logo of brand BioHarvest Sciences Inc. (BHST)

The market capitalization trend on GURU.Markets helps assess the financial stability of BioHarvest Sciences (BHST), whose indicators stand at 0.01. BioHarvest Sciences (BHST) relies on an innovative method of cultivating plant cells in bioreactors, creating sterile nutrients independent of weather conditions. Due to the absence of serious competitors in this niche, the business maintains pricing power, completely avoiding destructive price wars.

BHST (BioHarvest Sciences, Inc.) Company Short-Term Debts history from 11/13/2024 to 10/30/2026

Analytical breakdowns and data insights for company BioHarvest Sciences Inc (BHST)

- current quotes and average value forecast:
Price Chart BioHarvest Sciences Inc.|BHST - Fair Value Consensus
- market capitalization information:
Market Value BioHarvest Sciences Inc.|BHST - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share BioHarvest Sciences|BHST - Book Capitalization|Market Cap to Net Assets Ratio bioharvest.com|BHST - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity BioHarvest Sciences|BHST - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio BioHarvest Sciences|BHST - Company Cumulative Indebtedness|Debts to Book Capitalization BioHarvest Sciences Inc.|BHST - Company Long-Term Loans and Borrowings|Company Short-Term Debts BioHarvest Sciences|Quick Liquidity bioharvest.com
- net income and valuation multiples indicators:
BHST - Final Profit
Summary company analytics:BioHarvest Sciences Inc. (BHST)
Mass-produced product of bioharvest.com

BioHarvest Sciences expansion into North America is designed to mitigate geopolitical risks in the Israeli region. This indicator measures the aggregate of all liabilities with a maturity of up to one year. Liquidity analysis allows for an assessment of the business's ability to service operational loans without attracting external capital. Investors should compare debt dynamics with revenue growth rates. Total short-term debt on this chart serves as a marker of the company's financial stability.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TECX (Tectonic Therapeutic)|Tonix Pharma - Company Short-Term Debt|SXT China - Company Short-Term Debts|Short-Term Debt Volume Eupraxia Pharmaceuticals EPRX|eXoZymes Inc (EXOZ) - Company Short-Term Debt|Short-Term Debt Oramed Pharmaceuticals Inc. (ORMP)|ENTX (Entera Bio Ltd) - Company Short-Term Debts|HYFT: Company Short-Term Loans and Borrowings|Company Short-Term Debts ABVC|Company Short-Term Debts Cumberland Corp (CPIX)|Company Short-Term Debt Quantum BioPharma Ltd QNTM|Company Short-Term Loans and Borrowings FGEN|TELO: Company Current Liabilities|RANI: Company Short-Term Debt|SNYR: Company Short-Term Debts|Short-Term Debt Rallybio (RLYB)|Company Short-Term Debt Lexaria Bioscience Corp|pulmatrix.com (PULM) - Short-Term Debt Volume|Company Current Liabilities PTHL (Pheton Holdings Ltd)|Amount of Current Liabilities APM|Lyra Therapeutics, Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings IBO|TNFA - Company Short-Term Debt|Short-Term Debt Volume cbdMD, Inc. YCBD|PRFX: Company Short-Term Debts|Company Current Liabilities Altamira Therapeutics Ltd.|LIPO (Lipella) - Company Short-Term Debts|OptiNose Corp (OPTN) - Short-Term Debt Volume|Company Short-Term Debts PIRS|PROC - Short-Term Debt|Company Short-Term Debt Petros Pharmaceuticals, Inc. PTPI|QLI: Company Short-Term Indebtedness|ACELYRIN, Inc. - Company Short-Term Debts|TFF Pharmaceuticals, Inc (TFFP) - Company Current Liabilities